Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 11: Drugs and Performance-Enhancing Substances: A Scientific Statement From the American Heart Association and American College of Cardiology

J Am Coll Cardiol. 2015 Dec 1;66(21):2429-2433. doi: 10.1016/j.jacc.2015.09.043. Epub 2015 Nov 2.
No abstract available

Keywords: ACC/AHA Scientific Statements; athletes; cardiovascular abnormalities; drugs; performance-enhancing substances.

MeSH terms

  • Adolescent
  • Adult
  • Advisory Committees / standards
  • American Heart Association*
  • Athletes*
  • Cardiology / standards*
  • Cardiovascular Abnormalities / complications
  • Cardiovascular Abnormalities / diagnosis
  • Cardiovascular Abnormalities / drug therapy*
  • Child
  • Dietary Supplements*
  • Female
  • Humans
  • Male
  • Performance-Enhancing Substances* / administration & dosage
  • Practice Guidelines as Topic / standards
  • United States / epidemiology
  • Young Adult

Substances

  • Performance-Enhancing Substances